Centro de Investigación Biomédica en Red de Cáncer

CLIP Department of Paediatric Haematology and Oncology 2nd Faculty of Medicine Charles University Prague and University Hospital Motol Prague Czech Republic

Department of Genetics and Molecular Genetics

Department of Hematology University Hospital Claude Huriez Lille France

Department of Medical Research Chang Gung Memorial Hospital Linkou Taoyuan Taiwan

Department of Pediatric Hematology AP HP Robert Debré Hospital Paris France

Department of Pediatric Hematology Immunology and Oncology APHM La Timone Children Hospital Marseille France

Division of Hematology Oncology Department of Internal Medicine Chang Gung Memorial Hospital Chang Gung University Taipei Taiwan

Hematology Department CHU Hotel Dieu Nantes France

Hematology Department Hospital Clínic de Barcelona Institut d'Investigacions Biomèdiques August Pi i Sunyer

Hematopathology Section Hospital Clínic de Barcelona University of Barcelona Barcelona Spain

HSL Analytics LLP OncoGenomics London United Kingdom and UCL Cancer Institute UK

Institució Catalana de Recerca i Estudis Avançats Barcelona Spain; and

Institute of Pharmaceutical Biology Diagnostic Center of Acute Leukemia Goethe University Frankfurt Main Germany

Josep Carreras Leukemia Research Institute School of Medicine

Laboratoire d'Hématologie Hôpital Robert Debré Reims France

RICORS TERAV ISCIII Madrid Spain

Zobrazit více v PubMed

Malard F, Mohty M. Acute lymphoblastic leukaemia. Lancet. 2020;395(10230):1146-1162. PubMed

Papaemmanuil E, Gerstung M, Bullinger L, et al. . Genomic classification and prognosis in acute myeloid leukemia. N Engl J Med. 2016;374(23):2209-2221. PubMed PMC

Meyer C, Burmeister T, Gröger D, et al. . The MLL recombinome of acute leukemias in 2017. Leukemia. 2018;32(2):273-284. PubMed PMC

Türkmen S, Timmermann B, Bartels G, et al. . Involvement of the MLL gene in adult T-lymphoblastic leukemia. Genes Chromosom Cancer. 2012;51(12):1114-1124. PubMed

Rao N, Dodge I, Band H. The Cbl family of ubiquitin ligases: critical negative regulators of tyrosine kinase signaling in the immune system. J Leukoc Biol. 2002;71(5):753-763. PubMed

Schnittger S, Bacher U, Alpermann T, et al. . Use of CBL exon 8 and 9 mutations in diagnosis of myeloproliferative neoplasms and myelodysplastic/myeloproliferative disorders: an analysis of 636 cases. Haematologica. 2012;97(12):1890-1894. PubMed PMC

Loh ML, Sakai DS, Flotho C, et al. . Mutations in CBL occur frequently in juvenile myelomonocytic leukemia. Blood. 2009; 114(9):1859-1863. PubMed PMC

Saito Y, Aoki Y, Muramatsu H, et al. . Casitas B-cell lymphoma mutation in childhood T-cell acute lymphoblastic leukemia. Leuk Res. 2012;36(8):1009-1015. PubMed PMC

Shiba N, Park MJ, Taki T, et al. . CBL mutations in infant acute lymphoblastic leukaemia. Br J Haematol. 2012;156(5): 672-674. PubMed

Katzav S, Schmitz ML. Mutations of c-Cbl in myeloid malignancies. Oncotarget. 2015;6(13):10689-10696. PubMed PMC

Sanada M, Suzuki T, Shih L-Y, et al. . Gain-of-function of mutated C-CBL tumour suppressor in myeloid neoplasms. Nature. 2009;460(7257):904-908. PubMed

Fu JF, Hsu JJ, Tang TC, Shih LY. Identification of CBL, a proto-oncogene at 11q23.3, as a novel MLL fusion partner in a patient with de novo acute myeloid leukemia. Genes Chromosom Cancer. 2003;37(2):214-219. PubMed

Boneva T, Nacheva E. KMT2A-CBL fusion gene resulting from del(11)(q23.3q23.3) identified by chromosome microarray analysis-second report in AML. Atlas Genet Cytogenet Oncol Haematol. 2020;24(6):262-264.

Krivtsov AV, Armstrong SA. MLL translocations, histone modifications and leukaemia stem-cell development. Nat Rev Cancer. 2007;7(11):823-833. PubMed

So CW, Lin M, Ayton PM, Chen EH, Cleary ML. Dimerization contributes to oncogenic activation of MLL chimeras in acute leukemias. Cancer Cell. 2003;4(2):99-110. PubMed